There were 825 press releases posted in the last 24 hours and 219,477 in the last 365 days.


Please use this form to send email to PR contact of this press release:
LATITUDE Pharmaceuticals Receives USPTO Notice of Allowance for Novel Injectable Depot Formulation Platform

Anna M Ridenour
LATITUDE Pharmaceuticals, Inc.
858-546-0924 x118


Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image